INTRODUCTION
The gastrointestinal tract (GIT) is the primary site of digestion and absorption, with the most rapid turnover rate of any tissue in the body (Johnson, 1988; Cant et al., 1996) . The optimal growth of broiler chickens is considerably constrained by proper development of the small intestine, which is influenced largely by rapid cell proliferation, cellular hypertrophy, or a combination of the 2 processes (Morisset, 1993; Iji et al., 2001) . In newly hatched chickens, the small intestine is immature and grows at a faster rate than the BW, whereas the intestinal mucosa undergoes morphological, biochemical, and molecular changes (Iji et al., 2001) . In mature chickens, the small intestinal epithelium is continuously renewed by cell proliferation of enterocytes, which are mostly formed in the crypt, migrated up to the villi, and sloughed into the lumen from the villus tips (Uni et al., 2000; Iji et al., 2001 ). The intestinal development is not only affected by hormones such as insulinlike growth factor-I (IGF-I), epidermal growth factor (EGF), and cholecystokinin (CCK), but also responds to dietary constituents within the GIT (Johnson, 1988) .
Taurine, one of the end products of sulfur metabolism, is involved in many physiological events, including neuromodulation, osmoregulation, immunomodulation, antioxidation, retinal and cardiac function, and brain development. Present at high concentrations in the small intestine, taurine is thought to play an important role in the intestinal functions (Huxtable, 1992; Ahlman et al., 1993; Sturman, 1993; O'Flaherty et al., 1997) . Indeed, taurine was shown to exert its protective effect on gastric injury and colonic damage through its antioxidant properties (Son et al., 1996 (Son et al., , 1998 . Taurine is also capable of maintaining small intestinal mucosal thickness and villus height during total parenteral nutrition (Tsuchioka et al., 2006) . Additionally, taurine may play a role in maintaining normal serum IGF-I concentrations (Hu et al., 2000) , which promote intestinal development (Park et al., 1999) . These observations collectively suggested a possible role for dietary taurine in the maintenance of normal gastrointestinal development and functions.
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ABSTRACT Three experiments were conducted to determine the effect of taurine on the intestinal development, bile acid concentrations, and hormonal status of chickens. In experiment 1, a total of 250 one-day-old broilers were randomly allocated to 5 treatments and supplemented with 0, 0.25, 0.50, 1.00, and 2.00 g/kg of taurine, respectively. Growth performance, weight and length of the small intestine, and intestinal morphology were measured on d 7, 22, and 44. The gene expression levels of several hormones, including epidermal growth factor and cholecystokinin, were also evaluated. In experiment 2, 60 one-day-old broilers were supplemented with 0, 1.0, and 5.0 g/kg of taurine to assess cell proliferation in the jenunal crypt. In experiment 3, 100 newly hatched broilers were assigned randomly to 5 treatments (0, 0.10, 0.50, 2.00, 8.00 g/kg of taurine)
to evaluate the bile acid concentrations in the jejunal mucosa. Our results indicated that dietary taurine decreased the length and weight of small intestine, the villus width, surface area, and crypt depth in the duodenum and jejunum (P < 0.05). Taurine also increased the expression of cholecystokinin and epidermal growth factor on the jejunal mucosa (P < 0.001). Taurine has little effect on stimulating the proliferation of intestinal crypt cells, except for 5 g/kg of taurine supplementation on d 14 (P < 0.05). Additionally, a linear increase in the jejunal concentrations of taurocholic acid, taurochenodeoxycholic acid, and taurolithocholic acid was observed on d 7 in broilers fed increasing levels of taurine. In conclusion, we suggested that taurine impairs intestinal mucosal development partly through generation of toxic bile acids.
However, our previous study showed that taurine appeared to inhibit the development of the duodenum or jejunum in 6-wk-old broilers by increasing the total bile acid concentrations in the serum (Yuan and Wang, 2010) . It is well known that taurine has a crucial role in bile acid conjugation. Whereas bile acids can promote the absorption of dietary lipids, certain bile acids were cytotoxic at high concentrations (Hofmann, 1999; Amaral et al., 2009) . Moreover, addition of bile salts was observed to have a negative effect on the growth and morphology of the GIT (Maisonnier et al., 2003) . Therefore, the main objective of the current study was to characterize the effect of dietary taurine on normal intestinal mucosal development in broiler chickens at different ages. We hypothesized that taurine supplementation would suppress the growth of small intestinal mucosa by increasing the concentrations of toxic bile acids in the gut.
MATERIALS AND METHODS
All animal studies reported herein were approved by the Animal Care and Use Committee at China Agricultural University before initiation.
Experiment 1
Chemicals. Taurine was purchased from Shijiazhuang Richland Biochemical Co. (Shijiazhuang, China). All other chemical reagents were purchased from Sigma-Aldrich (St Louis, MO).
Diets and Bird Management. A total of 250 oneday-old broilers used in this experiment were obtained from a commercial hatchery and allotted randomly to 1 of 5 treatments with 5 replicate pens per treatment and 10 birds per pen. The control group was fed a standard maize-and soybean-based basal diet (Table 1) , whereas the experimental groups were fed the basal ration supplemented with taurine at 0.25, 0.50, 1.00, or 2.00 g/kg of diet. All birds were placed in wire cages; diets and nipple drinking water were provided ad libitum. Temperature was set at 34°C for 1-d-old broilers and gradually decreased to 20°C at 5 wk of age. The birds were provided 24 h of light the first week and then 23 h per day. All birds and feed were weighed for calculation of weight gain, feed intake, and feed-to-gain ratio on d 7, 22, and 42.
Sample Collection and Assessment. At 7, 22, and 44 d of age, 2 birds from each replicate pen of each treatment were killed with an intracardiac injection of 1 mL of sodium pentobarbital after 7 to 8 h of starvation. Duodenum, jejunum, and ileum were harvested for length measurement. The intestinal contents were then gently expelled by finger pressure, and empty intestinal segments were weighed. A 1-cm portion of each small intestinal segment were also collected in the middle and fixed in 10% buffered formalin for histological analysis. In addition, the mucosa and submucosa in the jejunum (Olympus Corporation, Tokyo, Japan) , and digital images were taken using video imaging software (ProgRes Capture Pro 2.7, Jenoptik AG, Jena, Germany). Images were used to measure the crypt depth, villus width at the crypt-villus junction, villus height, and villus apical width. Apparent villus surface area was estimated by trigonometry (Iji et al., 2001 ). Ten villi were assessed per sample.
Gene Expression Analysis. Total RNA was isolated from mucosal samples of the jejunum using TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations. Total RNA concentrations were measured based on the optical density at 260 nm using a UV spectrophotometer and its integrity was verified by agarose gel electrophoresis.
The cDNA was synthesized from 1 μg of total RNA using a 1-step RT(real-time)-PCR Kit (Takara Biotechnology, Dalian, China) and then was used for analysis of EGF, IGF-I receptor (IR), CCK, and β-actin mRNA abundance, respectively. The primers for EGF, IGF-IR, and CCK were designed using Primer Premier 5.0 (Premier Biosoft, Palo Alto, CA) based on the GenBank sequences (Table 2) . Desalted primers for the target genes were purchased commercially (SBS Genetech, Beijing, China).
Real-time PCR was performed using the ABI Prism 7700 Sequence Detector (Invitrogen). Two microliters of the RT products were amplified by PCR in a final volume of 20 μL containing 10 μL of 2 × SYBR Green PCR Master Mix (Thermo Fisher Scientific Inc., Waltham, MA), 1 μL of forward primer, and 1 μL of reverse primer. The PCR program consisted of 40 cycles of 30 s at 95°C for denaturation, 30 s at 55°C for annealing, and 55 s at 72°C for extension. Expression levels of EGF, IGF-IR, and CCK were normalized to those of the reference gene, β-actin. The relative fold changes were calculated and expressed relative to the control group.
Experiment 2
Sixty 1-d-old male broilers were randomly assigned to 1 of 3 treatment groups of 10 birds. The basal diet was the same as the first trial (Table 1) . Two experimental diets were formulated to contain an additional 1 and 5 g of taurine per kilogram of basal diet, respectively.
To study cell proliferation, 6 broilers from each treatment were injected with 5-bromo-2′-deoxyuridine (BrdU; Sigma-Aldrich) intraperitoneally at 50 mg/kg of BW on d 7, 14, and 21. Enterocyte proliferation was assessed by immunohistochemistry and computer-aided imaging analysis as described by Iji et al. (2001) . The labeling index of each sample, expressed as a percentage, was estimated in 12 crypts as the mean number of BrdU-positive nuclei of total crypt epithelial cells.
Experiment 3
Birds, Diets, and Sampling Protocol. Newly hatched male broiler chickens (n = 100) were obtained from a local hatchery (Beijing, China), and divided into 5 treatment groups with 2 pens per treatment and 10 broiler chickens per pen. Each treatment group received 1 of the 5 experimental diets ad libitum containing taurine in the basal diet at 0, 0.10, 0.50, 2.00, or 8.00 g/kg of dietary volume. All general management procedures were the same as for experiment 1. At 7 and 21 d of age, 6 chickens from each treatment were killed and the mucosal samples were collected in the same way as in experiment 1 and then stored at −80°C until analysis.
Analysis of Bile Acids in the Jejunal Mucosa. Taurocholic acid (TCA), taurochenodeoxycholic acid (TCDCA), taurodeoxycholic acid, and taurolithocholic acid (TLCA) were purchased from Sigma-Aldrich. Bile acid standards were prepared using methanol. The 0.2-M HCl-ethanol solution was prepared by dissolving HCl in absolute ethanol. The procedure of Manes and Schneider (1971) for extracting bile acids from intestinal mucosa was followed with slight modifications. Mucosal tissue (200 mg) was mixed with 2 mL of 0.2 M HCl-ethanol solution in a horizontal shaker (IKA, Königswinter, Germany) at 1,500 rpm for 30 s. The cap was placed on the tube, and it was ultrasonically agitated for 1 h, and centrifuged at 1,950 × g for 15 min (4°C). All supernatants were transferred to a new test tube. The extraction was repeated once with another 2 mL of 0.2 mM HCl-ethanol solution. The pooled extracts (~4 mL) were dried in nitrogen at 60°C. The samples were then dissolved in 0.4 mL of 20% acetonitrile solution (acetonitrile:water = 20:80) and passed through a 0.20-μm nylon syringe filter membrane before injection into HPLC. Conjugated bile acids were quantified by reversedphase HPLC. Gradient HPLC was done on an Agilent 1200 series using a UV detector with a C18 reverse phase Eclipse XDB column (4.6 × 150 mm; Agilent, Santa Clara, CA). The mobile phase A was 0.05% trifluoroacetic acid and mobile phase B was anhydrous acetonitrile. The flow-rate was 1 mL/min according to the following gradient: 0 to 2 min, 25% B; 2 to 12 min, 25 to 60% B; 12 to 16 min, 60% B; 16 to 18 min, 60 to 25% B; 18 to 26 min, 25% B. The conjugated bile acids were determined by UV detector (200 nm).
Statistical Analysis
All tests were performed using SPSS16.0 (SPSS Inc., Chicago, IL). The results are presented as means ± SEM. The statistical analyses were carried out using 1-way ANOVA followed by the Duncan post-test. Linear and quadratic effects were tested and considered significant if P < 0.05.
RESULTS

Experiment 1
Effect of Taurine on Growth Performance (Data Not Shown). Body weight, ADG, and ADFI did not differ among treatments at the age of 7, 22, or 42 d (P > 0.05). Feed-to-gain ratio decreased linearly (P = 0.027) as taurine increased in the diet in the first 7 d of age. However, feed-to-gain ratio was not significantly changed by the dietary treatments in the other periods (P > 0.05).
Effect of Taurine on the Morphology of the Small Intestine. The morphometric analyses of the 3 regions of the small intestine were performed. In the duodenum (Table 3) , a significant linear decrease (P < 0.05) in the weight and weight/length was observed at d 44. Crypt depth also declined linearly on d 7 (P < 0.05), and villus height-to-crypt depth ratio tended to decrease on d 22 (P = 0.059). The intestinal length on d 7 also decreased quadratically (P < 0.05) as taurine increased in the diet and tended to decrease quadratically on d 22 (P = 0.06). Treatment tended to have a quadratic effect on villus width and apparent villus surface area on d 44 (P < 0.01). The villus height was not affected by treatment (P > 0.05). In the jejunum (Table 3) , a linear increase in the intestinal weight was observed at the age of 7, 22, and 44 d with increasing dietary taurine (P < 0.05). Treatment tended to have a linear effect on the length at the age of 7 d (P = 0.054) and had a linear effect at the age of 44 d (P < 0.05). A quadratic increase in the villus height and crypt depth was noted on d 7 with increasing taurine (P < 0.05). The crypt depth on d 22, villus width on d 22, and the apparent villus surface area on d 22 decreased linearly as dietary taurine increased (P < 0.05). The villus height-to-crypt depth ratio at 22 and 44 d of age increased linearly (P < 0.05). In contrast to the control, villi in the jejunum of taurine-supplemented birds showed epithelial lifting and formation of large subepithelial gaps, and epithelial cells also frequently shed from the apical surfaces (Figure 1 ). In the ileum (Table 3) , the intestinal weight and the weight-to-length ratio at 22 d of age decreased linearly (P < 0.05).
Effect of Taurine on CCK, EGF, and IGF-IR Gene Expressions in the Jejunal Mucosa. The CCK and EGF mRNA levels showed a linear response to dietary taurine (P < 0.001), with a 3.3-and 4.6-fold increase, respectively, in broilers fed 2.00 g/kg of taurine as compared with those in the broilers fed a basal diet ( Figure  2A and B). Addition of taurine also had a tendency to linearly increase the IGF-IR mRNA levels (P = 0.09; Figure 2C ).
Experiment 2
Enterocyte proliferation index, as indicated by the percentage of BrdU-positive cells, did not vary with dietary taurine at the age of 7 and 21 d (P > 0.05; Table  4 ). However, dietary taurine at 5 g/kg significantly increased enterocyte proliferation (P < 0.05).
Experiment 3
Analysis of the concentrations of conjugated bile acids in the jejunal mucosa showed that a progressive increase occurred with TCA, TCDCA, and TLCA at 7 d of age, with the most predominant species being TCDCA (Table 5 ). The TCA and TLCA concentrations showed no difference among groups. No significant differences were observed for TCDCA concentration except supplemental 0.01% taurine, which significantly increased TCDCA concentration higher than that of other treatments at the age of 21 d. The cholesterol concentration in serum tended to increase at the age of 7 d (P = 0.051), whereas it did not differ at the age of 21 d.
DISCUSSION
Taurine was a major end product of cellular Cys catabolism in the animal intestinal mucosa (BauchartThevret et al., 2009 ) and played an important physiological role in intestinal tissues, particularly through antioxidation and bile acid conjugation (Huxtable, 1992; Son et al., 1996 Son et al., , 1998 . Addition of sulfate and Met enhanced the growth of chickens, partly through Values with different superscript letters in a row are significantly different (P < 0.05).
1 Number (n) of replicates per mean are 10 individuals for weight, length, and weight/length.
2
Eight individuals for villi height, crypt depth, villi width, apparent villus surface area, and villi height-to-crypt depth ratio. increasing the activity of enzymes for synthesis of taurine (Martin, 1972) , which in turn facilitated bile acid conjugation and fat absorption (Tufft and Jensen, 1992) . Conversely, sulfur amino acid deficiency could cause changes in performance associated with alteration of the gross growth, the epithelial cell proliferation, and the structure in small intestine (Bauchart-Thevret et al., 2009 ). In agreement with previous studies (Anderson et al., 1975; Tufft and Jensen, 1992) , the present study showed that dietary taurine increased the concentrations of taurine-conjugated bile acids in the jejunum on d 7 and had a beneficial effect on feed efficiency during the first week. This observation was also consistent with the fact that bile acid concentrations were low during the first week after hatch (Green and Kellogg, 1987) because of low activities of Cys sulfinate decarboxylase and, consequently, a low efficiency in the hepatic synthesis of taurine from Met and Cys (Huxtable, 1992) .This may help explain the difference between the growth performance in the first and later weeks.
Taurine is among the most abundant free amino acids in the duodenal and colonic epithelial cells. In humans, taurine in the duodenal mucosa was 90 to 100 times higher than in plasma (Ahlman et al., 1993) . We were especially interested in the effect of taurine supplementation on intestinal growth, as our previous study indicated that taurine appeared to inhibit the development of the duodenum and jejunum in 6-wk-old broilers (Yuan and Wang, 2010) . However, it was noted that our earlier study was only conducted in 42-d-old broilers with dietary taurine supplementation at 0.5 g/ kg. By increasing levels of dietary taurine and analyzing the intestinal development on d 7, 22, and 44, the present study further revealed that taurine could retard intestinal growth, showing weight reduction and length shortening. We showed that a greater effect of taurine could be seen in the jejunum than in the duodenum or ileum. As the villus area was linearly correlated with the intestinal wet weight (Uni et al., 1999) , the reduction of jejunal weight observed in the current study could be due to a decrease in villus surface area and villus width (Table 5) . We also determined the intestinal motility using Cr 2 O 3 and found that 0.5 g/kg of taurine could shorten intestinal transit time (data not shown), which might be due to a reduced length of the small intestine.
The crypt-villus axis was established with constant enterocyte proliferation and migration during the first 5 d posthatch (Uni et al., 2000) . Maintaining normal intestinal cell proliferation status is particularly important because the intestinal mucosal surface is formed by a continuous layer of epithelial cells. The BrdU, a thymidine analog that is incorporated into DNA during the S phase of the cell cycle, was commonly used to measure cell proliferation (Uni et al., 2000; Iji et al., 2001) . Our results showed that cell proliferation was rapid in the jejunum because approximately 37 to 48% of the cells were labeled within 1 h of BrDU administration (data not shown). One gram per kilogram of taurine supplementation appeared to have little effect on cell proliferation in the jejunal crypt, whereas dietary taurine at 5 g/kg significantly increased cell proliferation (P < 0.05). Higher levels of taurine may accelerate cell proliferation, which causes a greater need for cell replenishment and an increase in nutrient demand for the maintenance of the intestinal mucosa (Iji et al., 2001) . We were able to show that dietary taurine did induce the cell loss of mucosa (Figure 1 ). However, additional studies are needed to determine whether this is associated with increased cellular apoptosis in the villus tips or through other mechanisms. The regulation of the mucosal growth of the GIT, which is the largest endocrine organ in the body, is not only affected by dietary factors, but also by metabolic hormones (Morisset, 1993) . Epidermal growth factor could stimulate epithelial cell proliferation in duodenal, ileal, and colonic crypts of mice and the jejunal and ileal crypts of rats (Al-Nafussi and Wright, 1982) . Epidermal growth factor also exhibited a protective effect on injured mucosa (Dvorak et al., 2002) and played an important role in the maturation or development of the GIT (Morisset, 1993) . Insulin-like growth factor-I is another intestinal growth factor and hormone. Oral administration of IGF-I to piglets increased intestinal weight and mucosal weight (Park et al., 1999) , as well as intestinal disaccharidase activity and ileum villus height (Houle et al., 1997) . Taurine played a role in maintaining normal serum IGF-I concentrations in rat pups (Hu et al., 2000) . In the present study, an increased expression of EGF and IGF-IR in jejunal mucosa of taurine-treated chicks indicated that a greater demand might exist for endogenous EGF or IGF-I to stimulate cell proliferation, which compensated cell loss at the villus tips observed in experiment 1.
Cholecystokinin is a hormone contributing to gallbladder contraction, intestinal motility, satiety signaling, and modulation of gastric acid and pancreatic enzyme secretion. Inclusion of CCK increased bile acid synthesis (Dawes et al., 1997) . Taurine feeding could increase intestinal bile acid level (Bellentani et al., 1987) and lead to an increase in bile acid secretion rate and a predominance of taurine-over glycine-conjugated bile acids (Belli et al., 1988) . In the present study, we observed that taurine increased the mRNA expressions of CCK, which could help explain increasing levels of conjugated bile acids found in the jejunal mucosa of taurine-supplemented chickens.
As detergents to aid in the absorption of fat in the intestine, bile acids were toxic to cell membranes at high concentrations, with more hydrophobic species being more cytotoxic (Heuman et al., 1991) . For hepatocytes, 50% cytotoxicity was approximately 1 mmol/L for TCDCA and taurodeoxycholic acid and 10 t o15 mmol/L for TCA (Heuman et al., 1991) . In the present study, the concentrations of TCDCA in the taurinetreated group were 9 times higher than that in the control group. The accumulation of toxic bile acids in the serum, such as deoxycholic acid, could implicate in increased cell proliferation and cancer development or cell apoptosis in the GIT (Bayerdörffer et al., 1995) . Additionally, inclusion of sodium taurocholate (0.3%) in diets was shown to decrease the villus height of the duodenum and muscular wall thickness of the ileum as well as the relative weight and length of different segments of the GIT (Maisonnier et al., 2003) . Therefore, an increased concentration of taurine-conjugated bile acids might lead to mucosal injury. In conclusion, our study suggested that dietary supplementation of taurine retards intestinal growth, especially the jejunum, and impairs the subepithelial morphology partly by increasing the concentration of conjugated bile acids within the small intestine.
